<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02669576</url>
  </required_header>
  <id_info>
    <org_study_id>15-6578-BO</org_study_id>
    <nct_id>NCT02669576</nct_id>
  </id_info>
  <brief_title>Mind-Body Medicine Day Care Clinic in Breast Cancer Patients Undergoing Endocrine Therapy</brief_title>
  <acronym>ENDOTK</acronym>
  <official_title>Mind-Body Medicine Day Care Clinic in Breast Cancer Patients Undergoing Endocrine Therapy: A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universität Duisburg-Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universität Duisburg-Essen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial aims to investigate the effectiveness of a mind body day
      care clinic program of breast cancer patients undergoing endocrine therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Breast cancer patients undergoing endocrine therapy are often suffering from side effects.
      This randomized controlled trial analyzes the effects of an 11-week day care clinic group
      program including mind body medical elements (yoga, relaxation, meditation, education) and
      acupuncture in breast cancer patients with menopausal symptoms under endocrine therapy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Menopausal symptoms</measure>
    <time_frame>week 11</time_frame>
    <description>Menopause Rating Scale (MRS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>General health-related quality of life</measure>
    <time_frame>week 11</time_frame>
    <description>Functional Assessment of Cancer Therapy - General Questionaire (FACT-G)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spiritual health-related quality of life</measure>
    <time_frame>week 11</time_frame>
    <description>Functional Assessment of Cancer Therapy - Spirutual Subscale (FACT-SP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>week 11</time_frame>
    <description>Functional Assessment of Cancer Therapy - Fatigue Subscale (FACT-F)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental wellbeing</measure>
    <time_frame>week 11</time_frame>
    <description>Hospital Anxiety and Depression Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress</measure>
    <time_frame>week 11</time_frame>
    <description>Perceived Stress Scale (PSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance</measure>
    <time_frame>week 11</time_frame>
    <description>Medication Adherence Report Scale (MARS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>week 11</time_frame>
    <description>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Menopausal smptoms</measure>
    <time_frame>week 23</time_frame>
    <description>Menopause Rating Scale (MRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genaeral health-related quality of life</measure>
    <time_frame>week 23</time_frame>
    <description>Functional Assessment of Cancer Therapy - General Questionaire (FACT-G)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spiritual health-related quality of life</measure>
    <time_frame>week 23</time_frame>
    <description>Functional Assessment of Cancer Therapy - Spirutual Subscale (FACT-SP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>week 23</time_frame>
    <description>Functional Assessment of Cancer Therapy - Fatigue Subscale (FACT-F)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental wellbeing</measure>
    <time_frame>week 23</time_frame>
    <description>Hospital Anxiety and Depression Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress</measure>
    <time_frame>week 23</time_frame>
    <description>Perceived Stress Scale (PSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance</measure>
    <time_frame>week 23</time_frame>
    <description>Medication Adherence Report Scale (MARS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>week 23</time_frame>
    <description>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Mindfulness</measure>
    <time_frame>week 11</time_frame>
    <description>Conscious Presence and Self Control Scale (CPSC)</description>
  </other_outcome>
  <other_outcome>
    <measure>Social Support</measure>
    <time_frame>week 11</time_frame>
    <description>Berlin Social Support Scale (BSSS)</description>
  </other_outcome>
  <other_outcome>
    <measure>Expectation</measure>
    <time_frame>week 0</time_frame>
    <description>Visual Analogue Scale (VAS)</description>
  </other_outcome>
  <other_outcome>
    <measure>Statisfaction</measure>
    <time_frame>week 11</time_frame>
    <description>Client Satisfaction Questionnaire (CSQ)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Mind body medicine day care clinic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients recieve an 11-week mind body day care clinic including elements of mindfullness based stress reduction (MBSR), yoga, acupuncture, education</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients continue usual care by their practitioner</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mind body medicine day care clinic</intervention_name>
    <description>Patients recieve an 11-week mind body day care clinic including elements of mindfullness based stress reduction (MBSR), yoga, acupuncture, education</description>
    <arm_group_label>Mind body medicine day care clinic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Patients continue usual care by their practitioner</description>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histological diagnosed breast cancer (Stage I-III), no metastases

          -  Current endocrine therapy (minimum 3 months)

          -  Score of 9 or greater on the Menopausal Rating Scale (MRS)

          -  Signed informed consent

        Exclusion Criteria:

          -  Severe other somatic or psychiatric comorbidity

          -  Pregnancy

          -  Planned or existing chemotherapy, radiation or other cure treatment

          -  Participation in other clinical studies with behaviour-oriented, psychological or
             compementary medicine intervention.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustav Dobos, Prof. MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heidemarie Haller, Msc</last_name>
    <phone>004920117425044</phone>
    <email>h.haller@kliniken-essen-mitte.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kliniken Essen-Mitte</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45276</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gustav Dobos, Prof. MD</last_name>
      <phone>004920117425001</phone>
      <email>g.dobos@kliniken-essen-mitte.de</email>
    </contact>
    <investigator>
      <last_name>Heidemarie Haller, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2016</study_first_submitted>
  <study_first_submitted_qc>January 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2016</study_first_posted>
  <last_update_submitted>October 10, 2017</last_update_submitted>
  <last_update_submitted_qc>October 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universität Duisburg-Essen</investigator_affiliation>
    <investigator_full_name>Heidemarie Haller</investigator_full_name>
    <investigator_title>MSc</investigator_title>
  </responsible_party>
  <keyword>Breast cancer</keyword>
  <keyword>meopausal syptoms</keyword>
  <keyword>mind body medecine</keyword>
  <keyword>yoga</keyword>
  <keyword>acupuncture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

